Control of immune pathology by IL-10-secreting regulatory T cells
Control of immune pathology by IL-10-secreting regulatory T cells
复制标题
DOI:
10.1007/s002810050068
复制
发表时间:
1999-12-01
期刊:
影响因子:
--
通讯作者:
Powrie, F
中科院分区:
文献类型:
--
作者:
Fowler, S;Powrie, F
The same effector mechanisms that have evolved to protect the host from invading micro-organisms can, if inappropriately regulated, induce immune pathology. A number of diseases owe their pathogenicity to the induction of aberrant immune responses. For example, inflammatory bowel disease (IBD) involves the activation of pathogenic T cells responding to or driven by bacterial antigens, and autoimmune disease is a consequence of the activation of the immune system by the hosts own tissues. The development of cerebral malaria in genetically susceptible individuals is attributed to parasite-induced TNF production [15], indicating that an over zealous or dysregulated immune response to an infectious agent can also induce disease. Despite the ability of the immune system to kill the host, inflammatory diseases are infrequent, suggesting that there are mechanisms that limit the immune response and, in some instances, suppress it completely. There is now accumulating evidence that functionally specialised populations of regulatory T cells (Treg) play a dominant role in this process. T cells with the characteristics of Treg have been described in a number of model systems [25]. In this review we focus on those cells secreting the immunosuppressive cytokines IL-10 and transforming growth factor-[3 (TGF-I]).